Stay updated with breaking news from Director Jerome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) have been given an average rating of “Hold” by the fourteen analysts that are covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and four have issued a buy recommendation on […]
Piper Sandler cut shares of Itron (NASDAQ:ITRI – Free Report) from an overweight rating to a neutral rating in a research report sent to investors on Tuesday, Marketbeat.com reports. They currently have $109.00 price target on the scientific and technical instruments company’s stock. Other equities research analysts have also recently issued research reports about the […]
PTC Therapeutics (NASDAQ:PTCT – Free Report) had its target price hoisted by JPMorgan Chase & Co. from $43.00 to $53.00 in a research report released on Tuesday morning, Benzinga reports. They currently have an overweight rating on the biopharmaceutical company’s stock. A number of other brokerages also recently weighed in on PTCT. Cantor Fitzgerald reissued […]
Shares of Itron, Inc. (NASDAQ:ITRI – Get Free Report) have received an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and eight have issued a buy rating on the company. The average 12 month […]
Victory Capital Management Inc. boosted its position in shares of Itron, Inc. (NASDAQ:ITRI – Free Report) by 31.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,122 shares of the scientific and technical instruments company’s stock after buying an additional 3,338 shares during the […]